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Abstract
Background: The accurate diagnosis and management of febrile urinary tract infection (UTI) is a clinical challenge in the absence
of specific clinical and laboratory findings in infants and young children.
Objectives: The aim of this study was to identify and compare the diagnostic and therapeutic implications of recently introduced
cytokines for the diagnosis of acute pyelonephritis (APN).
Methods: This multicenter prospective study was performed on 37 (female/male = 6.5:1) children with symptomatic culture-proven
APN and 37 (female/male = 1.6/1) age-matched febrile children without UTIs as the control group. Urine samples were obtained before
antibiotic treatment in both groups and 3 - 4 days after treatment in the UTI group, and evaluated for interleukin (IL)-1α, IL-1β, IL-2,
IL-4, IL-6, IL-8, IL-10, tumor necrosis factor-α (TNFα), monocyte chemoattractant protein-1 (MCP-1), and vascular endothelial growth
factor (VEGF) using an ELISA immunoassay kit.
Results: Mean urinary IL-1α, IL-4, IL-6, and IL-8 concentrations significantly increased in the acute phase of APN compared to the
control group, and decreased following antibiotic treatment.
Conclusions: We recommend routine urinalysis and urine culture for the diagnosis of children with APN. Urinary IL-4 was a rela-
tively good cytokine for the prediction and treatment-monitoring of children with acute febrile UTI.
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1. Background
Urinary tract infection (UTI) is the most common se-
rious bacterial infection in febrile infants and young chil-
dren, second to otitis media and pharyngitis (1). The early
diagnosis of acute febrile UTI is based on clinical manifes-
tations and a few laboratory tests with limited accuracy.
Urine culture testing is the gold standard for the diagnosis
of UTI, but requires 2 - 3 days for the identification of the re-
sponsible organism, with false-positive and false-negative
results. In addition, urinalysis and inflammatory mark-
ers, such as fever, white blood cell (WBC) count, erythro-
cyte sedimentation rate (ESR), and C-reactive protein (CRP),
have limited sensitivity and specificity for the diagnosis of
acute pyelonephritis (APN) (2-4). The DMSA renal scan is an-
other option for the diagnosis of APN, with positive find-
ings in 50% of patients with a febrile UTI, and it has been
recently recommended for the evaluation of renal damage
3 - 6 months following an acute febrile UTI (5). According to
these limitations, new sensitive and noninvasive diagnos-
tic tests, including cytokines, have been introduced for the
accurate diagnosis of febrile UTI (3, 6).
2. Objectives
The aim of this study was to identify and compare the
sensitivity, specificity, and accuracy of urinary ILs to sug-
gest the most valuable test for the diagnosis of APN, com-
pared to conventional diagnostic markers.
3. Methods
This prospective cross-sectional study was conducted
over a 1-year period from 2014 - 2015 on 74 children. It was
approved by the institutional ethics committee, and in-
formed consent was obtained from the parents. The study
protocol conforms to the ethical guidelines of the 1975 dec-
laration of Helsinki.
A total of 37 children with APN were compared with 37
children in an age-matched control group with other bac-
terial infections, such as pneumonia, meningitis, arthritis,
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and otitis, with a fever of > 38.5°C and increased WBC, ESR,
and CRP. Patients with congenital anomalies of the urinary
tract (CAKUT), neurogenic bladder, immunodeficiency, re-
nal dysfunction, or recent antibiotic treatment were ex-
cluded from the study.
Urine samples were collected by suprapubic aspiration
or urethral catheterization during early infancy and by
the midstream technique in older children. APN was de-
fined as a UTI (any growth from suprapubic aspiration sam-
ples, growth of > 105 CFU/mL from midstream or urine-
bag collections, or > 104 from urethral catheterizations)
associated with a fever of > 38.5°C, leukocytosis (WBC
> 13,000/mm3), increased ESR, pyuria, and positive CRP.
Pyuria was defined as > 5 WBC/hpf of voided urine on cul-
ture.
DMSA scans were performed on patients with ultra-
sonographic abnormal scarred kidneys or on ill patients
with suspected APN within the first 5 - 7 days of admission.
DMSA scans showed pyelonephritic changes as focal or dif-
fuse areas of decreased cortical uptake, with the preserva-
tion of renal contour in 60% of patients.
Systemic inflammatory markers, such as WBC, ESR, and
CRP levels, were evaluated at the time of presentation.
Urine samples were obtained before antibiotic treatment
in both groups and 48 - 72 hours after treatment in the
UTI group, and frozen at -80°C until examination. Urinary
concentrations of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-6,
IL-8, and IL-10), tumor necrosis factor-α (TNFα), monocyte
chemoattractant protein-1 (MCP-1), and vascular endothe-
lial growth factor (VEGF) were analyzed with a newly intro-
duced commercially available ELISA kit (Randox laborato-
ries, UK) according to the manufacturer’s instructions. The
results were expressed as ng/mL.
All tests were analyzed using SPSS for Windows (version
13.0, SPSS Inc., Chicago, IL, USA). Continuous variables were
compared with independent-sample t-tests and ANOVA,
and the categorical variables were compared with Fisher’s
exact or chi-square tests. P values of < 0.05 were consid-
ered statistically significant.
4. Results
A total of 37 patients (female/male = 6.5/1) with UTIs
and 37 patients (female/male = 3.6/1) with non-UTI febrile
infections were enrolled in this study. The mean age of the
UTI group was 39.01± 27.99 months, compared to 44.05±
32.10 months in the control group (P = 0.697). There was
no significant difference in terms of fever, WBC, and ESR be-
tween the two groups. However, qualitative serum CRP was
significantly higher in the UTI group compared to the con-
trol group (P = 0.001). Escherichia coli was the most often
encountered microorganism, isolated in more than 85% of
patients, followed by Klebsiella, Enteroccuus, and Proteus in
the majority of patients. None of our patients had positive
blood cultures.
The mean levels of urinary IL-1α (2.62±4.70, P = 0.005),
IL-4 (2.31± 0.56, P = 0.000), IL-6 (29.94± 63.78, P = 0.015),
and IL-8 (419.93 ± 608.91, P = 0.001) were significantly
higher in the UTI group than in the control group. IL-1α
(0.98± 2.40), IL-4 (2.19± 0.55), IL-6 (5.68± 11.52), and IL-8
(173.82± 431.98) were decreased 3 - 4 days following antibi-
otic treatment (Table 1). IL-1β (P = 0.001, r = 0.421) and IL-4 (P
= 0.000, r = 0.434) had significant correlations with serum
CRP. Moreover, patients with abnormal 99mTc-DMSA scans
had significantly higher urinary IL-6 (P = 0.014) and MCP-1
concentrations (P = 0.001) (Table 2).
5. Discussion
Both mucosal and systemic inflammatory mediators,
including cytokines and chemokines, are activated in the
early phase of bacterial infections, with proinflammatory
and immunoregulatory functions (7-9). They are involved
in B cell and T cell proliferation and neutrophil chemoat-
traction, along with secretion of CRP, immunoglobulins,
and acute-phase proteins (2, 6, 8, 10)
Clinical manifestations of APN depend on the produc-
tion of different cytokines, and measurement of urinary
ILs seems to be useful for the rapid diagnosis and local-
ization of inflammation within the urinary tract system.
Increased urinary IL-1, IL-4, IL-6, and IL-8 concentrations
have been reported in children with acute febrile UTIs
compared to the healthy children and those with lower
UTIs, asymptomatic bacteriuria, and non-renal febrile in-
fections (2, 11-15). Similarly, urinary IL-1, IL-4, IL-6, and IL-8
increased during the acute phase of infection compared
to non-renal febrile infections. Despite previous reports of
increased urinary IL-2 and IL-10 concentration in patients
with APN (14, 16). We did not find significant increases of
these two biomarkers.
Previous studies showed rapid elimination of uri-
nary cytokines after the initiation of antibiotic treatment.
Therefore, the determination of urinary ILs is helpful for
the evaluation of treatment response in APN, and persis-
tently elevated urinary IL concentrations indicate treat-
ment modifications (6, 9, 17). Accordingly, increased uri-
nary IL levels decreased following antibiotic treatment and
were considered for therapeutic monitoring in our pa-
tients.
A significant correlation has been reported between cy-
tokine response and the severity of infection (9, 11). IL-1β
was significantly correlated with CRP and WBC in a study
by Sheu et al. (2). Urinary IL-1 and IL-4 were independently
correlated with serum CRP in our study. However, Renata
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Table 1. Comparison of Variables in Children With and Without UTI (all Variables are Measured in ng/mL and Expressed as mean± SD).
Variable Pre-Treatment Post-Treatment Control P-Value
IL-1α 2.62± 4.70 0.98± 2.40 0.31± 0.47 0.005
IL-1β 11.33± 26.77 12.36± 63.92 0.77± 0.77 0.393
IL-2 0.96± 1.28 1.68± 1.42 1.13± 1.32 0.068
IL-4 2.31± 0.56 2.19± 0.55 1.52± 0.35 0.000
IL-6 29.94± 63.78 5.68± 11.52 7.86± 16.54 0.015
IL-8 419.93± 608.91 173.82± 431.98 20.33± 16.63 0.001
IL-10 1.03± 0.20 1.05± 0.29 1.13± 0.50 0.491
TNF-α 1.19± 0.38 1.24± 0.37 1.23± 0.43 0.844
MCP-1 162.3± 260.7 69.60± 83.51 191.8± 407.9 0.168
VEGF 81.17± 68.08 70.58± 50.32 92.98± 407.9 0.688
Table 2. Correlation of Urinary Biomarkers With Systemic Inflammatory Response, Pyuria, and DMSA Scan in Patients With UTIs (all Variables are Expressed as P-Values and
Measured in ng/mL).
Variable WBC ESR CRP Urine WBC DMSA Scan
IL-1α 0.864 0.616 0.050 0.462 0.995
IL-1β 0.474 0.608 0.001 0.304 0.36
IL-2 0.706 0.567 0.967 0.580 0.395
IL-4 0.699 0.303 0.000 0.723 0.578
IL-6 0.850 0.125 0.70 0.063 0.014
IL-8 0.790 0.384 0.057 0.012 0.905
IL-10 0.550 0.809 0.752 0.389 0.115
TNF-α 0.409 0.921 0.877 0.974 0.179
MCP-1 0.654 0.705 0.741 0.061 0.001
VEGF 0.271 0.134 0.798 0.054 0.645
found no correlation between ILs and systemic inflamma-
tory markers in febrile UTI (10) . Urinary IL-6 increased in
accordance with DMSA parenchymal defects in the acute
phase of pyelonephritis in our patients, in line with previ-
ous studies (18).
TNF-αwas the other evaluated inflammatory mediator
of serious bacterial infections in this study, as it is a rapid
and reliable test for the diagnosis of upper UTIs (3, 19) and
is decreased following antibiotic treatment (20) However,
TNF-α levels showed no significant changes in Lin’s study
(18) which is similar to our results.
MCP-1 is a component of proinflammatory chemotac-
tic cytokines, called chemokines, involved in immune and
inflammatory responses. Increased MCP-1 levels were de-
tected in patients with UTIs at admission, at least in part
locally produced, and were decreased with specific treat-
ment in a study by Olszyna et al. (21) Similarly, urinary MCP-
1 increased during the acute phase of febrile UTIs and de-
creased following antibiotic treatment in our patients, al-
though with a non-significant correlation. We showed that
a positive correlation between MCP-1 and DMSA renal scans
was the most reliable indicator of acute parenchymal in-
fections.
Our cytokine kit included VEGF, or vascular permeabil-
ity factor (VPF), which is a glycosylated protein with va-
sodilator, angiogenetic, and inflammatory effects. How-
ever, this showed no significant change in our patients and
was not considered an accurate index for the diagnosis of
febrile UTI.
In conclusion, urinary IL-4 was a relatively sensitive
and accurate biomarker for the differentiation of APN from
other infectious disorders in the present study. However,
simple and inexpensive tests, such as urinalysis and urine
cultures, are still recommended for the diagnosis of chil-
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dren with APN. Urinary IL-4 is suggested as a useful test for
the identification of APN in highly suspicious patients with
false-positive or false-negative urine results, to prevent un-
necessary radiologic evaluations and long-term follow-up.
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